Brawn Biotech (BOM:530207) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Brawn Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Brawn Biotech's Free Cash Flow for the three months ended in Dec. 2023 was ₹0.0 Mil. Brawn Biotech's Revenue for the three months ended in Dec. 2023 was ₹28.4 Mil. Therefore, Brawn Biotech's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Brawn Biotech's current FCF Yield % is 2.70%.

The historical rank and industry rank for Brawn Biotech's FCF Margin % or its related term are showing as below:

BOM:530207' s FCF Margin % Range Over the Past 10 Years
Min: -2.81 Med: 0.1 Max: 2.24
Current: 1.37

During the past 13 years, the highest FCF Margin % of Brawn Biotech was 2.24%. The lowest was -2.81%. And the median was 0.10%.

BOM:530207's FCF Margin % is ranked better than
53.79% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.06 vs BOM:530207: 1.37

Brawn Biotech FCF Margin % Historical Data

The historical data trend for Brawn Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brawn Biotech FCF Margin % Chart

Brawn Biotech Annual Data

Trend

Mar13

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

0.32

-0.19

0.10

-1.37

1.08

Brawn Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Brawn Biotech's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Brawn Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brawn Biotech's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brawn Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Brawn Biotech's FCF Margin % falls into.

Brawn Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Brawn Biotech's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	2.224	/	206.737
	=	1.08 %

Brawn Biotech's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	28.428
	=	0.00 %

Brawn Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Brawn Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Brawn Biotech (BOM:530207) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brawn Biotech Ltd (BOM:530207) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Plot No. 30, Sector 33, Near Hero Honda Factory, Gurugram, HR, IND, 122001

Website

https://www.brawnbiotech.com

Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.

Brawn Biotech (BOM:530207) Headlines

No Headlines